After a long weekend, there's much to do. There will be FDA meetings today about Glaxo's Avandia and, tomorrow, about Biogen's Tysabri. And, of course, the usual stream of items. Here are a few to get you started....
Maryland Legislator Proposes Discounts For Low-Income Workers (The Washington Post)
Viagra May Treat Non-Sexual Disorders, Study Says (The Economic Times)
Sanofi-Aventis May Use Share Buyback To Appease Investors (Bloomberg News)
AstraZeneca Sues Finland's Orion Over Patents (Reuters)
Pfizer's Aricept Shows Benefit In Severe Alzheimer's (PharmaTimes)





